Ezra Klein of the New York Times considers the healing potential of psilocybin mushrooms in an op-ed that covers the success of Oregon's Measure 109, which creates a "support infrastructure through which psychedelic mushrooms can be woven into everyday life."
Klein shares the "cautious" yet supportive perspective of MAPS Founder and Executive Director Rick Doblin, Ph.D., on the initiative: "I worry those with the most at stake in terms of licenses will be fearful of participating, when those are the people we most want to participate."
Read more
Vice asks if it’s possible to create an ethical psychedelics company… what do you think?
Read more
A growing body of evidence suggests that the psychedelic compound found in "magic mushrooms" could help ease depression symptoms.
Read more
Researchers have shown that psilocybin -- the active chemical in 'magic mushrooms' -- still works its antidepressant-like actions, at least in mice, even when the psychedelic experience is blocked. The new findings suggest that psychedelic drugs work in multiple ways in the brain and it may be possible to deliver the fast-acting antidepressant therapeutic benefit without requiring daylong guided therapy sessions.
Read more
As psychedelic toads are pushed to the limit, conservationists urge synthetic 5-MeO-DMT is the best option.
Read more
This article reports that as more people turn to psychedelics, integration proves a crucial factor for breakthroughs.
Read more